ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Efficacy of conversion from bedtime NPH insulin to morning insulin glargine in type 2 diabetic patients on basal-prandial insulin therapy
Diabetes Research and Clinical Practice
◽
10.1016/j.diabres.2005.12.009
◽
2006
◽
Vol 73
(1)
◽
pp. 35-40
◽
Cited By ~ 37
Author(s):
Hiroki Yokoyama
◽
Junko Tada
◽
Futayo Kamikawa
◽
Sakiko Kanno
◽
Yuki Yokota
◽
...
Keyword(s):
Insulin Glargine
◽
Insulin Therapy
◽
Diabetic Patients
◽
Type 2 Diabetic Patients
◽
Nph Insulin
◽
Prandial Insulin
◽
Prandial Insulin Therapy
◽
Type 2 Diabetic
Download Full-text
Related Documents
Cited By
References
IGF-I Bioactivity Decreases during Insulin Therapy in Type 2 Diabetic Patients: Comparison of High Doses of Insulin Glargine and NPH Insulin in the LANMET Study
10.1210/endo-meetings.2011.part4.or11.or39-5
◽
2011
◽
pp. OR39-5-OR39-5
◽
Cited By ~ 1
Author(s):
Aimee J Varewijck
◽
Joseph AMJL Janssen
◽
Markku Vahatalo
◽
Steven WJ Lamberts
◽
Hannele Yki-Jarvinen
Keyword(s):
Insulin Glargine
◽
Insulin Therapy
◽
Diabetic Patients
◽
Type 2 Diabetic Patients
◽
Nph Insulin
◽
Igf I
◽
High Doses
◽
Type 2 Diabetic
Download Full-text
Addition of insulin glargine or NPH insulin to metformin monotherapy in poorly controlled type 2 diabetic patients decreases IGF-I bioactivity similarly
Diabetologia
◽
10.1007/s00125-011-2435-7
◽
2012
◽
Vol 55
(4)
◽
pp. 1186-1194
◽
Cited By ~ 14
Author(s):
A. J. Varewijck
◽
J. A. M. J. L. Janssen
◽
M. Vähätalo
◽
L. J. Hofland
◽
S. W. J. Lamberts
◽
...
Keyword(s):
Insulin Glargine
◽
Diabetic Patients
◽
Type 2 Diabetic Patients
◽
Nph Insulin
◽
Metformin Monotherapy
◽
Igf I
◽
Type 2 Diabetic
Download Full-text
Health Care Cost Avoidance Due to Insulin Glargine for Type 2 Diabetic Patients in Hong Kong as Compared to NPH Insulin
Value in Health
◽
10.1016/j.jval.2013.08.735
◽
2013
◽
Vol 16
(7)
◽
pp. A451
Author(s):
K.K. Lee
◽
D.B.C. Wu
Keyword(s):
Health Care
◽
Hong Kong
◽
Insulin Glargine
◽
Health Care Cost
◽
Diabetic Patients
◽
Type 2 Diabetic Patients
◽
Nph Insulin
◽
Cost Avoidance
◽
Type 2 Diabetic
Download Full-text
Concentrations of Insulin Glargine and Its Metabolites During Long-Term Insulin Therapy in Type 2 Diabetic Patients and Comparison of Effects of Insulin Glargine, Its Metabolites, IGF-I, and Human Insulin on Insulin and IGF-I Receptor Signaling
Diabetes
◽
10.2337/db12-1773
◽
2013
◽
Vol 62
(7)
◽
pp. 2539-2544
◽
Cited By ~ 18
Author(s):
A. J. Varewijck
◽
H. Yki-Jarvinen
◽
R. Schmidt
◽
N. Tennagels
◽
J. A. M. J. L. Janssen
Keyword(s):
Insulin Glargine
◽
Insulin Therapy
◽
Human Insulin
◽
Diabetic Patients
◽
Receptor Signaling
◽
Type 2 Diabetic Patients
◽
Igf I
◽
Type 2 Diabetic
Download Full-text
The Impact of Adding Prandial Insulin to a Basal Based Regimen with Insulin Glargine in Type 2 Diabetic Patients
Medical Journal of the Islamic Republic of Iran
◽
10.47176/mjiri.35.177
◽
2021
◽
Author(s):
Mohammad Ebrahim Khamseh
◽
Zahra Abbasi Ranjbar
◽
Zahra Banazadeh
◽
Mani Mirfeizi
◽
Manouchehr Mohammadbeiki
◽
...
Keyword(s):
Insulin Glargine
◽
Diabetic Patients
◽
Type 2 Diabetic Patients
◽
Prandial Insulin
◽
The Impact
◽
Type 2 Diabetic
Download Full-text
Sodium-Glucose Cotransporter 2 Inhibitors Reduce Prandial Insulin Doses in Type 2 Diabetic Patients Treated With the Intensive Insulin Therapy
Journal of Clinical Medicine Research
◽
10.14740/jocmr3392w
◽
2018
◽
Vol 10
(6)
◽
pp. 493-498
Author(s):
Mariko Hakoshima
◽
Hidekatsu Yanai
◽
Kouki Kakuta
◽
Hiroki Adachi
Keyword(s):
Insulin Therapy
◽
Intensive Insulin Therapy
◽
Diabetic Patients
◽
Type 2 Diabetic Patients
◽
Prandial Insulin
◽
Sodium Glucose Cotransporter
◽
Type 2 Diabetic
Download Full-text
Safety and efficacy of insulin glargine (HOE 901) versus NPH insulin in combination with oral treatment in Type 2 diabetic patients
Diabetic Medicine
◽
10.1046/j.1464-5491.2003.00999.x
◽
2003
◽
Vol 20
(7)
◽
pp. 545-551
◽
Cited By ~ 52
Author(s):
Keyword(s):
Insulin Glargine
◽
Oral Treatment
◽
Diabetic Patients
◽
Type 2 Diabetic Patients
◽
Nph Insulin
◽
Safety And Efficacy
◽
Type 2 Diabetic
Download Full-text
Treatment duration (persistence) of basal insulin supported oral therapy (BOT) in Type-2 diabetic patients: comparison of insulin glargine with NPH insulin
International Journal of Clinical Pharmacology and Therapeutics
◽
10.5414/cp201572
◽
2012
◽
Vol 50
(01)
◽
pp. 24-32
◽
Cited By ~ 9
Author(s):
Renate Quinzler
◽
Miriam Ude
◽
Alexandra Franzmann
◽
Sandra Feldt
◽
Katrin Schüssel
◽
...
Keyword(s):
Insulin Glargine
◽
Basal Insulin
◽
Treatment Duration
◽
Oral Therapy
◽
Diabetic Patients
◽
Type 2 Diabetic Patients
◽
Nph Insulin
◽
Type 2 Diabetic
Download Full-text
Initiating Insulin Therapy in Type 2 Diabetic Patients Failing on Oral Hypoglycemic Agents: Basal or prandial insulin? The APOLLO trial and beyond
Diabetes Care
◽
10.2337/dc09-s319
◽
2009
◽
Vol 32
(suppl_2)
◽
pp. S260-S265
◽
Cited By ~ 16
Author(s):
R. G. Bretzel
◽
M. Eckhard
◽
W. Landgraf
◽
D. R. Owens
◽
T. Linn
Keyword(s):
Insulin Therapy
◽
Hypoglycemic Agents
◽
Diabetic Patients
◽
Oral Hypoglycemic Agents
◽
Type 2 Diabetic Patients
◽
Prandial Insulin
◽
Type 2 Diabetic
Download Full-text
Effects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine
Cardiovascular Diabetology
◽
10.1186/s12933-017-0549-z
◽
2017
◽
Vol 16
(1)
◽
Cited By ~ 6
Author(s):
Weena J. Y. Chen
◽
Michaela Diamant
◽
Karin de Boer
◽
Hendrik J. Harms
◽
Lourens F. H. J. Robbers
◽
...
Keyword(s):
Randomized Controlled Trial
◽
Cardiac Function
◽
Insulin Glargine
◽
Controlled Trial
◽
Diabetic Patients
◽
Type 2 Diabetic Patients
◽
Randomized Controlled
◽
Type 2 Diabetic
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close